Our series of research videos show what it’s like to have five different types of assessment for dementia. This post shows how one of them – the amyloid PET scan – is becoming a vital part of research ...

Paul shares that he was diagnosed with Alzheimer's disease in 2025 and has been receiving support from Alzheimer's Society. BBC Radio 2 and Greatest Hits Radio presenter Paul Gambaccini, aged 77, has ...

Social prescribing is used in health and social care, where people can live better by improving social and environmental aspects of their lives. Social prescribing has been found to benefit people ...

As well as following our main Twitter account (@alzheimerssoc) and Facebook page, you can also follow social media accounts based in your local area. You'll get more information about local events and ...

What could help people with dementia to stay independent and well for longer? Researchers are exploring a range of answers, all of which need to be tested by people living with the condition to make ...

Take on the incredible Trek26 Cotswolds challenge and walk 13 or 26 miles. Explore the rural landscape of the Cotswolds as you trek through ancient woodlands, wildflower meadows and historic Cotswold ...

It's time to think differently about dementia, will you join us? Alzheimer’s Society Annual Conference 2026 will bring together health and social care leaders, policymakers, campaigners, researchers ...

Many people living with dementia will want to continue working. Read about your rights in the workplace and how to talk to your employer about your dementia diagnosis. Getting a diagnosis of dementia ...

Rhymes and engaging illustrations to help start conversations and relieve anxieties about someone close who may have dementia. Aimed at four- to 10-year-olds. My Grandma Has Dementia, by Alex ...

A new dementia risk score 'calculator' identifies people potentially at risk of developing the disease within the next 14 years, according to a study published by The British Medical Journal (BMJ). A ...

Dr Richard Oakley, Associate Director of Research at Alzheimer’s Society, has called breakthrough Alzheimer's drug donanemab, 'a turning point', as the full trial results were revealed. Full results ...